Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Catherine, born with Down syndrome and Tetralogy of Fallot (TOF), a rare congenital heart condition, has regained her quality of life after undergoing a novel Venus P™ valve implantation at the ...

Cardiology, one of the most vital fields of modern medicine, focuses on the heart and the circulatory system that sustains it. It includes the study, diagnosis, treatment, and prevention of ...

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Edwards Lifesciences (NYSE: EW) announced today that it provided the founding sponsorship for a new AHA Heart Valve ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the 2025 Transcatheter Cardiovascular Therapeutics (TCT) ...

The Phase 2, randomized, double-blind clinical trial included 23 patients randomized to either 200 mg ataciguat (n=12) or placebo (n=11) once daily for a 12-month period. The primary Phase 2 clinical ...

More than 10 million older adults in the U.S. have mild or greater valvular heart disease and the prevalence is expected to grow over the next several decades, according to data from the PREVUE-VALVE ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...